The government has decided to resume AstraZeneca's COVID-19 vaccination from tomorrow (12th), but it has decided to exclude those under the age of 30, making it inevitable to modify the vaccination plan.
Among the targets for AstraZeneca vaccination in the second quarter, it is estimated that 640,000 people were under the age of 30, because separate measures have not yet been prepared for them.
In a regular briefing, Eun-kyung Chung, head of the COVID-19 vaccination and response promotion, said, "Because we do not recommend AstraZeneca vaccine for those under the age of 30, we need to get another vaccine." “We need to provide a complementary plan to determine when to place it.”
General Manager Jung said, "We are in the process of discussing the introduction of Janssen and NovaVax vaccines, and we are negotiating to receive Pfizer vaccines earlier, so if a vaccine supply plan is decided, it will be decided in consideration of the priority of vaccination according to the scope. I will do it."
However, the current global vaccine supply and demand situation is unstable, and as a result, Janssen, NovaVax, and Modena vaccine have not even been confirmed in the domestic initial volume, so there is also concern that the goal of forming'November collective immunity' will be disrupted. Is coming out.
Of the 1,8088,000 vaccines secured by the government in the first half of this year, AstraZeneca vaccines accounted for 1,674,000 doses, accounting for 59% of the total.
(Photo = Yonhap News)